DNA Interstrand Cross-Linking Agents and their Chemotherapeutic Potential

被引：46

作者：

Brulikova, L. ^{[1
]}

Hlavac, J. ^{[1
]}

Hradil, P. ^{[1
]}

机构：

[1] Palacky Univ, Fac Sci, Inst Mol & Translat Med, Dept Organ Chem, Olomouc 77146, Czech Republic

来源：

CURRENT MEDICINAL CHEMISTRY | 2012年 / 19卷 / 03期

关键词：

Chemotherapy; cytotoxicity; DNA; interstrand cross-link; ICL; repair; resistance; NUCLEOTIDE EXCISION-REPAIR; FANCONI-ANEMIA PATHWAY; GROUP DOMAIN PROTEINS; MINOR-GROOVE; ANTITUMOR-ACTIVITY; CANCER CELLS; IN-VITRO; ATAXIA-TELANGIECTASIA; REDUCTIVE ACTIVATION; SELECTIVE INHIBITOR;

D O I：

10.2174/092986712803414295

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

DNA interstrand cross-linking (ICL) agents are an important group of cytotoxic drugs with the capability of binding covalently between two strands of DNA, thereby preventing vital processes such as replication or transcription in dividing cells. In anticancer therapy however, their potential is limited due to the resistance by various mechanisms. In order to develop highly effective antitumor drugs it is necessary to study both effective ICL formations and their subsequent repair mechanisms. This review presents an overview of development over the past decade and the use of both well-known and new DNA interstrand cross-linking agents. Their potential in applications especially as anticancer chemotherapeutics in the framework of current knowledge of repair mechanisms and development of combined chemotherapy is discussed.

引用

页码：364 / 385

页数：22

共 136 条

[31] The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01 [J].

Graves, PR ;

Yu, LJ ;

Schwarz, JK ;

Gales, J ;

Sausville, EA ;

O'Connor, PM ;

Piwnica-Worms, H .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5600-5605

[32] Synthesis of the first examples of A-C8/C-C2 amide-linked pyrrolo[2,1-c][1,4]benzodiazepine dimers [J].

Gregson, SJ ;

Howard, PW ;

Thurston, DE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (14) :2277-2280

[33] Synthesis of a novel C2/C2′-exo unsaturated pyrrolobenzodiazepine cross-linking agent with remarkable DNA binding affinity and cytotoxicity [J].

Gregson, SJ ;

Howard, PW ;

Jenkins, TC ;

Kelland, LR ;

Thurston, DE .

CHEMICAL COMMUNICATIONS, 1999, (09) :797-798

[34] Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity [J].

Gregson, SJ ;

Howard, PW ;

Hartley, JA ;

Brooks, NA ;

Adams, LJ ;

Jenkins, TC ;

Kelland, LR ;

Thurston, DE .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (05) :737-748

[35] A mammalianized synthetic nitroreductase gene for high-level expression [J].

Grohmann, Maik ;

Paulmann, Nils ;

Fleischhauer, Sebastian ;

Vowinckel, Jakob ;

Priller, Josef ;

Walther, Diego J. .

BMC CANCER, 2009, 9

[36] Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy [J].

Guainazzi, Angelo ;

Schaerer, Orlando D. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (21) :3683-3697

[37] Psoralen interstrand cross-link repair is specifically altered by an adjacent triple-stranded structure [J].

Guillonneau, F ;

Guieysse, AL ;

Nocentini, S ;

Giovannangeli, C ;

Praseuth, D .

NUCLEIC ACIDS RESEARCH, 2004, 32 (03) :1143-1153

[38]

Hartley JA, 2000, ANGEW CHEM INT EDIT, V39, P3467

[39] SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.: Part 1:: Cellular pharmacology, in vitro and initial in vivo antitumor activity [J].

Hartley, JA ;

Spanswick, VJ ;

Brooks, N ;

Clingen, PH ;

McHugh, PJ ;

Hochhauser, D ;

Pedley, RB ;

Kelland, LR ;

Alley, MC ;

Schultz, R ;

Hollingshead, MG ;

Schweikart, KM ;

Tomaszewski, JE ;

Sausville, EA ;

Gregson, SJ ;

Howard, PW ;

Thurston, DE .

CANCER RESEARCH, 2004, 64 (18) :6693-6699

[40] Synthesis, cytotoxicity and DNA cross-linking activity of symmetrical dimers based upon the epoxide domain of the azinomycins [J].

Hartley, JA ;

Hazrati, A ;

Hodgkinson, TJ ;

Kelland, LR ;

Khanim, R ;

Shipman, M ;

Suzenet, F .

CHEMICAL COMMUNICATIONS, 2000, (23) :2325-2326

← 1 2 3 4 5 6 7 8 9 10 →